Icon

Lysteda - (650 mg; Tablet)

Tranexamic Acid Ferring
650 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
None
Less Than 5
Less Than 5
Used to treat heavy menstrual bleeding. Tranexamic acid prevents enzymes in the body from breaking down blood clots.
Yes
****** *** ****** *** *** ***** ** **** (***) **** ** **** ****** '*** - *** *, **** *** ************ ********* ** ******* ** *** ******** ***** ** ******. ***** ****** *** ****** **** ***** **** *** **** ******* '*** *** '*** **** ******** ** *** *, **** *** ************ ********* ** *******.
Lysteda Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
****** ******* ******* ******* ******* ******* ******* ******* *******
****** ******* ******* ******* ******* ******* ******* ******* *******
***** ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ *** *** **, **** ******* ******** ******** ** *** *, ****
****** *** \ ** *** **, **** ******* ******** ************ *********
***** ** \ ** *** *, **** ******* **** ****** **** ********
  1. *** **, **** : ****** ******** ******* ***** *** **** ** **** ****** '*** - *** *, ****.
  2. *** **, **** : ****** ******** ******* ***** *** **** ** **** ****** '*** - *** *, ****.
  3. **** *, **** : ******* **** **** ****** *** ****** ** ******** ** ******.
  4. *** **, **** : ******* ******** ******* **** **** ****** *** ****** ********* **** *** **** ****** '*** - *** *, **** *** **** **** ** ******** ** ******.
  5. *** *, **** : ******* ******** ******* **** **** ****** *** ****** ********* **** *** **** ****** '*** - *** *, ******* **** **** ** ******** ** ******.
  6. *** *, **** : ****** ******** ***** ********.
  7. *** *, **** : ******* ***** * **** ******* ***** ** ******* '***, '***, '*** *** '***.
  8. *** **, **** : ********** ********* **** ******
  9. *** **, **** : ********** ********* **** *****
  10. *** *, **** : ********** ********* **** ******
  11. *** **, **** : ******* ******** ****** ** ***** **** ** ******
  12. *** **, **** : ****** **** ******* **** ************ ** ******* '***, '***, '***, '***, '***, '***, '***, *** '***.
  13. *** **, **** : ****** *** ******* ******* ******* *** ********* **********. ** ****** ** ** **********.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.